Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability

Exploring mesoporous silica microparticles in pharmaceutical sciences: Drug delivery and therapeutic insights

Nanotechnology has revolutionised pharmaceutical sciences, with mesoporous silica nanoparticles (MSNs) extensively studied as drug carriers. However, their clinical translation is hindered by challenges such as toxicity, tumour accumulation, and uncontrolled endocytosis. Mesoporous silica microparticles (MSMs) have emerged as a safer alternative, offering enhanced drug loading, controlled release, and improved formulation properties. MSMs facilitate protein delivery, solubility enhancement, and bioavailability improvement through pore size modulation, amorphous drug loading, and surface functionalisation. Additionally, they aid in overcoming multi-drug resistance and enable organ-specific targeting using aptamers or magnetic nanoparticles. Beyond drug delivery, MSMs enhance pharmaceutical formulations, with commercial products such as SYLOID®, Aeroperl®, and Neusilin® improving tablet performance and drug stability. Their role in controlled release systems further underscores their pharmaceutical potential. As research advances, MSMs offer promising strategies for precision medicine and optimised drug delivery, reinforcing their potential for future clinical applications.

Designing of moringa gum-zwitterionic copolymer structure through supra-molecular and covalent interactions for biomedical uses

Recently, functional materials derived from carbohydrate polymers have gained significant attention for their clinical uses due to their inherent bioactivity and biocompatibility. Therefore, the primary focus of the present research was to design bioactive moringa gum (MOGUM)-based hydrogels through covalent and supra-molecular interactions for use in biomedical applications. The copolymeric hydrogels were prepared by crosslinking of zwitterionic polymers of 2-(methacryloyloxy)ethyl] dimethyl-(3-sulfoproyl) ammonium hydroxide (MEDSAH) and carbopol (CP) onto gum for their applications in hydrogel wound dressings (HWDR) and drug delivery (DD). These copolymers were characterized by field emission scanning electron microscopy (FESEM), energy-dispersive X-ray (EDX), atomic force microscopy (AFM), Fourier transform infrared spectroscopy (FTIR), solid state 13C nuclear magnetic resonance (13C NMR), X-ray diffraction (XRD) and differential scanning calorimetry (DSC) techniques. Release of the encapsulated drug (minocycline) from hydrogels exhibited non-Fickian mechanism and the release profile was best described by zero order kinetic model. These HWDR were found to be blood compatible, mechanically stable, permeable to H2O and O2. The HWDR revealed muco-adhesiveness and required a detachment force 153.00 ± 6.00 mN for their separation from mucosal membrane. The antioxidant activity of dressing materials revealed 76.57 ± 1.91 % scavenging during the DPPH assay. The minocycline encapsulated HWDR elucidated antibacterial activity against P. aeruginosa, E. coli & S. aureus. These findings suggest that these hydrogels hold significant potential for application in DD systems.

Tailor-made Biochar enhances the anti-tumour effects of butyrate-glycerides in colorectal cancer

Colorectal cancer (CRC) is the third most common cancer and the second cause of cancer death in the world. Emerging evidence suggests that the short-chain-fatty-acid butyrate diet-assumed or produced by gut microbiota may interfere with CRC. Novel, more focused and effective anti-cancer natural molecules selectively acting on tumour cells are required to improve patients' compliance compared to more aggressive drug-based schemes. This study explored the in vitro anti-cancer effects of a novel green compound consisting of butyrate-glycerides (BMDG) alone or absorbed on tailor-made Biochar (BMDG-Biochar) or on activated-carbon Norit-B (BMDG-Norit), by using two CRC cell lines, HCT116 and HT29. Tailor-made Biochar characterised by a larger share of meso and macroporosity compared to commercially available activated-carbon Norit-B, with micro-pored ultrastructure, displayed superior performances as a BMDG carrier, with higher absorption/release properties. BMDG, in particular when absorbed on Biochar, interfered significantly with CRC cell proliferation compared to BMDG-Norit that showed no effect. Analysis of cell metabolism revealed a superior sensitivity of HCT116 to the inhibitory effect of BMDG-Biochar. This compound specifically induced a shift from a glycolytic metabolism in particular in HCT116 cells where glycolysis supports the aggressive phenotype, towards the mitochondrial respiration that characterises the more differentiated and less aggressive HT29 cells. Biochar's ability to deliver the butyrate-glyceride bioactive mixture and to exert in vitro combined anti-cancer activity in colorectal cancer, interfering with the Warburg effect that characterises the aggressive CRC forms, opens future translational opportunities to develop new orally assumed green molecules as promising anti-cancer strategies for CRC.

Paclitaxel and myricetin encapsulated hemoglobin nanoparticles: characterization and application

Hb is used as a carrier protein to encapsulate hydrophobic drugs PTX and MYN and has applications in cancer treatment. PTX and MYN encapsulated Hb NPs are synthesized by the acid denature method and are characterized by spectroscopic and electron microscopic techniques. The binding constant calculated for Hb and PTX is 3.83 x 108 M-1, which is the highest in the pH range tested for both drugs. The CD spectra also demonstrated maximum denaturation of Hb at pH 5.0 evidencing the opening of the Hb hydrophobic core. The acidic condition at pH 5.0 is optimized for the synthesis of drug- encapsulated NPs. FTIR spectra of Hb PTX NPs recorded higher shifts in the OH/carboxyl peak compared to Hb-MYN. SEM images of Hb-PTX NPs highlight the tetrahedral structure of the NPs and the round shape of Hb-MYN NPs. The size of Hb-MYN and Hb-PTX is around 38.0 and 44.0 nm respectively as measured by DLS. PTX-Hb NPs demonstrated higher dose-dependent apoptosis-inducing efficacy than MYN-Hb in the K562 cells.

Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet

This study outlines the development of a cost-effective, extended-release febuxostat (FEB) tablet using activated charcoal as an adsorbent to enhance drug release. FEB, a BCS Class II drug, presents formulation challenges due to low solubility and high lipophilicity. We evaluated eight formulations with varying FEB-to-charcoal ratios using FTIR and DSC for physical interactions and followed USP standards for overall assessment. The optimal 1:0.25 FEB-to-charcoal ratio demonstrated a consistent 12 h zero-order release pattern. In vivo studies indicated a significantly extended plasma profile compared to immediate-release tablets. The optimal tablets demonstrated acceptable hardness and disintegration times. This innovative approach enhances patient compliance, improves bioavailability, and reduces production costs, offering a promising solution for controlled FEB delivery.

Unravelling pH/pKa influence on pH-responsive drug carriers: Insights from ibuprofen-silica interactions and comparative analysis with carbon nanotubes, sulfasalazine, and alendronate

This study employs density functional theory to explore the interaction between ibuprofen (IBU) and silica, emphasizing the influence of the trimethylsilyl (TMS) functional group for designing pH-responsive drug carriers. The surface (S) and drug (D) molecules' neutral (0) or deprotonated (-1) states were taken into consideration during the investigation. The likelihood of these states was determined based on the pKa values and the desired pH conditions. To calculate the pH-dependent interaction energy (EintpH), four different situations have been identified: S0D0, S0D-1, S-1D0, and S-1D-1.The electrostatic component of interaction energy aligns favorably with its theoretical value in both the Debye-Hückel and Grahame models. The investigation has gathered first-hand experimental data on the drug loading and release of pH-responsive mesoporous silica nanoparticles. Effective drug loading was observed in the acidic environment of the stomach (pH 2-5), followed by a release in the slightly basic to neutral pH of the small intestine (pH 7.4), These findings align with existing literature. The results revealed horizontal drug adherence on silica surfaces, improving binding capabilities. Comparisons were made with combinations involving carboxylated carbon nanotubes and ibuprofen, silica, and sulfasalazine, and silica and alendronate, exploring drug loading/release dynamics associated with positive/negative interaction energies. The investigation, supported by experimental data, contributes valuable insights into pH-responsive mesoporous silica nanoparticles, offering new design possibilities for drug carriers.

Molecular Dynamics of Hydration Shells of Adsorbates in Entropy-Driven Adsorption (Hydrophobic Bonding) to Activated Carbon Surfaces

Hydrophobic bonding is a phenomenon wherein the adsorption of solutes from aqueous solutions is driven largely by the desire of solvent molecules to interact with each other, thus squeezing out solute molecules onto the adsorbent surface. A novel computational analysis of hydration shell water dynamics was used to study the driving force for the hydrophobic bonding of five small drug molecules to activated carbon. It was demonstrated that the solvation of these drug molecules produced hydration shells of lower density and molecular mobility than bulk water, up to 10.5-14 Å distance. Excellent correlations were found between the simulated water-water hydrogen bonding lifetimes in the hydration shell and the experimental capacity constants of hydrophobic bonding (KHB) obtained from the Two-Mechanism Langmuir-Like Equation. KHB also correlated well with the solute-solvent vdW interaction energies in a manner that could allow future predictions of KHB values from simple simulations. Such correlations were not found with the capacity constant of the well-known enthalpy-driven adsorption. The driving force for hydrophobic bonding has entropic origins due to the elimination of water structuring in the hydration shells. However, unlike a typical entropy-driven process, hydrophobic bonding to activated carbon was also associated with a large exothermic enthalpy change when studied with isoperibol calorimetry.

Enhanced dissolution of anticancer drug letrozole from mesoporous zeolite clinoptilolite

High dissolution of anticancer drugs directly adsorbed onto porous carriers is indispensable for the development of drug delivery systems with high bioavailability. We report direct adsorption/loading of the anticancer drug letrozole (LTZ) onto the clinoptilolite (CLI) zeolite after the surface activation.In vitroLTZ dissolution from the CLI zeolites reached 95 % after 23 h in an acidic medium, being faster than the dissolution of the pure LTZ molecules. Fast dissolution occurs due to uniform exposure of the LTZ onto the external surface of the CLI zeolites, being accessible to the solvent for dissolution. On the other hand, the LTZ molecules were hidden in the bulk phase, giving a slow dissolution rate. Small positive value of the CLI/LTZ adsorption energy of 0.06 eV suggests that the release process is favourable in aqueous media. The main merit of the CLI/LTZ system is its quick onset of action and high bioavailability. This work demonstrates a possibility of enhancement of the dissolution of poorly soluble LTZ from the CLI zeolite, being promising for the further development of drug delivery systems.

Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles

The production of solid lipid nanoparticles (SLNs) is challenging, especially when considering the incorporation of biologics. A novel in-house method of microfluidic production of biologic-encapsulated SLNs is proposed, using a variety of base materials for formulation to help overcome the barriers presented during manufacture and administration. Trypsin is used as a model drug for hydrophilic encapsulation whilst testosterone is employed as a positive non-biologic lipophilic control active pharmaceutical ingredient. Particle sizes obtained ranged from 160 to 320 nm, and a lead formulation has been identified from the combinations assayed, allowing for high encapsulation efficiencies (47-90%, respectively) of both the large hydrophilic and the small hydrophobic active pharmaceutical ingredients (APIs). Drug release profiles were analysed in vitro to provide useful insight into sustained kinetics, providing data towards future in vivo studies, which displayed a slow prolonged release for testosterone and a quicker burst release for trypsin. The study represents a large leap forward in the field of SLN production, especially in the field of difficult-to-encapsulate molecules, and the technique also benefits from being more environmentally sustainable due to the use of microfluidics.

Theoretical insights and implications of pH-dependent drug delivery systems using silica and carbon nanotube

In this paper we have studied the density functional theory of four drugs ibuprofen, alendronate, Sulfasalazine and paracetamol with quartz, propylamine, trimethylamine functionalized quartz and carboxyl modified carbon nanotube. The attractive and repulsive interaction energies between drugs and quartz is obtained at various pH values. The attractive and repulsive energies are well correlated with experimental drug loading and releasing behavior by mesoporous silica nanoparticles. Further, a theoretical model is developed that accounts the electrostatic interaction between silica and drug and the model can predict the drug loading and releasing behavior by silica nanoparticles at various pH values. Sulfasalazine can be taken orally and loaded with trimethyl ammonium functionalized mesoporous silica nanoparticles, which keeps the drug in tact with the carrier in the acidic environment of the stomach and releases it into the neutral or basic medium of the small intestine. Alendronate may be loaded and released from propylamine functionalized mesoporous silica nanoparticles in the ranges of 1-5 and > 8, respectively. Ibuprofen is absorbed in an acidic environment and released in basic conditions for carboxyl modified carbon nanotube. The loading and releasing pH ranges for paracetamol in trimethylammonium functionalized mesoporous silica nanoparticles are 4-8 and >8, respectively. We also convert the pH-dependent variant of the diffusion-controlled Higuchi equation. We have changed the original Higuchi equation to produce the pH-dependent variation by incorporating the Nernst-Planck equation into Flick's first law. The updated equation could be used to forecast when medication particles with varying release times will emerge from a nanoparticles matrix.

Hydrothermal effect of gunningite use Pluronic F127-GELATIN as template and the ibuprofen adsorption performance

The gunningite has been successfully synthesized using Pluronic F127 and gelatin as template via hydrothermal at 100-200 °C for 12-48 h. By scanning electron microscopy, nitrogen adsorption-desorption, and X-ray diffraction, changes in structure, pore size, and morphology due to ibuprofen adsorption were investigated in gunningite. Various hydrothermal (temperature and time) parameters had an influence on the percentage elimination (%) of ibuprofens. Gunningite's specific surface area intensifies from 14.60 to 24.03 m²/g as the longer hydrothermal time. In batch adsorption studies, the resulting sample was conducted to isotherm and kinetic analysis to evaluate the distribution of ibuprofen between the liquid and solid phases. Pseudo-first-order kinetics with an adsorption capacity range of 27-34.5 mg g^-1 were the best fit for the observed data. Consequently, gunningite may be considered a viable adsorbent for the large-scale treatment of water contaminated with ibuprofen and related anti-inflammatory medicines.

Muscle cytotoxicity and immuno-reactivity analysis of the porous carbon nanospheres fabricated by high temperature calcination

Carbon-based nanomaterials have a high specific surface area, biocompatibility, and controlled mesopore structures. These characteristics make carbon nanospheres excellent carriers for drugs, biological dyes, photosensitizers, etc. Nevertheless, little is known about the impact of topological features on the surface of carbon nanomaterials on their in vivo immunoreactivity. In this study, we fabricated mesoporous carbon nanoparticles (MCNs) and solvent-processable carbon vesicles (CVs) by high-temperature calcination. The hematoxylin and eosin (H&E) staining suggested CVs' relatively poor dispersion capacity compared to MCNs and carbon precursors (CPs), leading to more severe muscle inflammation and necrosis. Immunostaining and Fluorescence Activated Cell Sorter (FACS) analysis further showed that both MCNs and CVs triggered a transient immune response in transplanted muscle and muscle-draining lymph nodes, but did not alter muscle resistance to exogenous viruses. In conclusion, this study provides insights into how carbon nanoparticles modulate the activation of immune responses in vivo.

Fluidized or not fluidized? Biophysical characterization of biohybrid lipid/protein/polymer liposomes and their interaction with tetracaine

BACKGROUND

Nanomedicine and the pharmaceutical industry demand the investigation of new biomaterials to improve drug therapies. Combinations of lipids, proteins, and polymers represent innovative platforms for drug delivery. However, little is known about the interactions between such compounds and this knowledge is key to prepare successful drug delivery systems.

METHODS

Biophysical properties of biohybrid vesicles (BhVs) composed of phospholipids, proteins, and amphiphilic block copolymers, assembled without using organic solvents, were investigated by differential scanning calorimetry and dynamic light scattering. We studied four biohybrid systems; two of them included the effect of incorporating tetracaine. Thermal changes of phospholipids and proteins when interacting with the amphiphilic block copolymers and tetracaine were analyzed.

RESULTS

Lysozyme and the copolymers adsorb onto the lipid bilayer modifying the phase transition temperature, enthalpy change, and cooperativity. Dynamic light scattering investigations revealed relevant changes in the size and zeta potential of the BhVs. Interestingly, tetracaine, a membrane-active drug, can fluidize or rigidize BhVs.

CONCLUSIONS

We conclude that positively charged regions of lysozyme are necessary to incorporate the block copolymer chains into the lipid membrane, turning the bilayer into a more rigid system. Electrostatic properties and the hydrophilic-lipophilic balance are determinant for the stability of biohybrid membranes.

GENERAL SIGNIFICANCE

This investigation provides fundamental information associated with the performance of biohybrid drug delivery systems and can be of practical significance for designing more efficient drug nanocarriers.

Evaluation of cytotoxicity, oxidative stress and organ-specific effects of activated carbon from Al-Baha date palm kernels

Background

Activated carbon (AC) is a carbonaceous material derived from carbonization and activation of carbon-containing compounds at high temperature and has a large surface area, providing it with excellent adsorption properties. Human exposure to ACs via ingestion is increasing and, unfortunately, there is little to no evidence related to its level of toxicity

Materials and methods

Activated carbon of powdered date kernels from Al-Baha city in Saudi Arabia were used to treat rats and cell lines (HepG2 and HCT-116). Toxicity, microbiological tests and biochemical analyses were carried out to investigate biological activity of both commercially available AC (CAC), pharmaceutical AC (PAC) and AC from date palm kernels (AAC)

Results

None of the ACs showed activity on Staphylococcus aureus, Bacillus subtilis, Protius mirabilis and Escherichia coli. AAC showed the most cytotoxic effect on both HCT-116 and HepG2 cell lines after 24 h, with IC50 of 48.7 ± 17.2 µg/ml and 51 ± 6.24 µg/ml respectively. Rats treated with AAC for 48 h showed no impairment of hepatic and renal functions, unlike those exposed to CAC and PAC. Similarly, AAC-exposed rats did not show oxidative stress in both the liver and kidneys while CAC and PAC exposure resulted in depletion of CAT, GPx, SOD and GSH in both organs. L-arginase and α-fucosidase expression were also induced by both PAC and CAC while α-fucosidase levels were unaffected in AAC-exposed rats

Conclusion

AAC appears to be biologically safe compared with PAC and CAC due to its antioxidant activities and non-effect on both hepatic and renal functions.

Activated Carbon for Drug Delivery from Composite Biomaterials: The Effect of Grinding on Sirolimus Binding and Release

Activated carbon (AC) could be potentially useful as a drug carrier in fiber polymer scaffolds destined for prolonged drug delivery. To be introduced, AC must be ground into smaller-sized particles to be introduced in scaffolds, as most biocompatible scaffolds consist of fibers with a diameter of less than 1 µm. In this study, the adsorption of sirolimus (SRL) from phosphate-buffered saline (PBS) solution and blood plasma (BP) onto AC of AX-21 type, as well as the release of SRL from AC depending on its fragmentation, were studied. Two-stage grinding of the AC, first with a ball mill, and then with a bead mill, was performed. Grinding with a bead mill was performed either in water or in polyvinylpyrrolidone to prevent aggregation of AC particles. Dynamic light scattering and scanning electron microscopy (SEM) demonstrated that the size of the particles obtained after grinding with a ball mill was 100–10,000 nm, and after grinding with a bead mill, 100–300 nm. Adsorption in PBS was significantly higher than in BP for all fractions, and depended on SRL concentration. The fraction obtained after grinding with a ball mill showed maximal SRL adsorption, both in PBS and BP, and slow SRL release, in comparison with other fractions. The 100–300 nm AC fractions were able to adsorb and completely release SRL into BP, in contrast to other fractions, which strongly bound a significant amount of SRL. The data obtained are to be used for controlled SRL delivery, and thus in the modification of drug delivery in biological media.

Drug-loaded mesoporous carbon with sustained drug release capacity and enhanced antifungal activity to treat fungal keratitis

Fungal keratitis is a severe infectious corneal disease with a high rate of incidence and blindness. Since traditional treatments natamycin (NATA) eye drops, exhibit poor dissolution and bioavailability, and the efficacy of current therapeutic approaches remains limited. In this study, we innovatively utilized mesoporous carbon (Meso-C) and microporous carbon (Micro-C) as nanocarriers loaded with the antifungal drug NATA and silver nanoparticles (Ag-NPs). Porous carbon loaded with NATA and Ag-NPs has not previously been studied in fungal keratitis. Due to the mesoporous structure, high surface area and larger pore volume of Meso-C, it displayed greater superiority in sustained drug release and drug dispersity than Micro-C. Moreover, Meso-C could adsorb inflammatory cytokines during fungal infection. In vitro, Meso-C/NATA/Ag showed excellent antifungal effects. In vivo, compared with pure NATA treatment, Meso-C/NATA/Ag exhibited significantly improved therapeutic effects and reduced dosing frequency when treating fungal keratitis. Our study is the first to report the sustained drug release and improved drug dispersity of Meso-C/NATA and demonstrates that NATA and Ag-NPs-loaded Meso-C has therapeutic effects against fungal keratitis.

Novel Application for Activated Carbon Pharmaceutical Formulation as an Efficient Adsorbent of Iron (III) from Contaminated Canned Food

Additional medical indication has been realized for the active carbon commercialized in pharmaceutical stores for the first time. In this study, the active carbon was used to remove iron (III) from real canned food samples contaminated with iron by an adsorption process, in a new approach. Different parameters affecting the adsorption behavior of active carbon towards iron (III) have been optimized. Under the optimized conditions, namely, pH 4, 5 h contact time, 40 ppm iron initial concentration, and 2 g carbon, the study was applied to some of the real canned food samples. Black olive and green bean canned food samples containing relatively high iron levels of 698.0 and 1168 mg kg-1, respectively, have been selected for this study due to their levels which were above the maximum permitted levels 48 mg kg-1 according to the Joint FAO/WHO Expert Committee on Food Additives (JECFA). These samples were digested and treated, and their iron concentration was determined using ICP-AES under the specified optimum conditions. The removal percentage of the real samples was ~91%. In a novel approach, this study simulates the adsorption behavior of active carbon towards iron (III) in the human stomach when canned food with relatively high iron levels has been digested, since the pH value of the human stomach (~3) comes in good agreement with the adsorption optimized pH range (2-4). Moreover, the overall tolerability and safety of active carbon are worldwide known and traditionally documented. These application studies realize the applicability of utilizing active carbon commercially available in pharmaceutical stores to eliminate the toxicity of canned food contaminated by high levels of the investigated elements.

Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill

A novel orally bioavailable solid formulation to deliver a gaseous signaling molecule, carbon monoxide (CO), was developed by adsorbing oxalyl saccharin, a newly developed organic CO prodrug, in activated charcoal (AC). The resulting solid dispersion formulation addresses key developability issues of this CO prodrug. By taking advantage of the large surface area of AC, the paradoxical problem of low water solubility of the prodrug and the requirement of hydrolysis to release CO is resolved, and the need for an organic cosolvent is completely circumvented. The AC formulation also mitigates the adverse effect of low pH on the CO release yield, allowing steady CO release in simulated gastric and intestine fluids. This formulation allows encapsulation in normal and enteric-coated gel capsules, which enables controllable CO delivery to the upper or lower GI system. It also features an advantage of trapping CO prodrug and CO release product in the AC, therefore lowering systemic absorption of these chemicals. Through in-vivo pharmacokinetic studies in mice, the AC formulation showed better efficiency of delivering CO through oral administration compared to the prodrug dosed with an organic cosolvent. The AC formulation has also been applied to address similar developability issues of another cheletropic reaction-based CO prodrug. We envision the wide applicability of this formulation in facilitating the future development of CO-based therapeutics.

Applicability of modified carbon sorbent for removing potentially toxic biologically active molecules of aromatic structure from blood plasma

The modification of the mesoporous carbon sorbent with 3-phenylpropanoic acid was carried out in order to create preparations of complex, prolonged action, exhibiting detoxifying, antibacterial, and antifungal properties due to the applied modifier, which is capable of migrating into the solution and exhibiting its own biospecific properties. A technique was developed for fixing 3-phenylpropionic acid (PhPA) on a carbon support by its adsorption from solution. Three types of sorbents with various content of the modifier (PhPA) and the sorbent without modifier were studied. The sorption activity of new sorbents was studied using liquid-liquid extraction and gas chromatography-mass spectrometry methods on model experiments with plasma and aqueous additives of hydroxylated phenyl-containing acids (PhCAs) in various concentrations. The specific surface area was significantly changed for sorbent, modified with 1 × 10^-3 mol/L of PhPA solution, and was 25% less than the area of unmodified sorbent. Potentially toxic biologically active hydroxylated PhCAs were used to create model solutions. The degrees of sorption of these compounds were close to 100%, except phenyllactic acid (over 80%). The sorbent without modifier and two sorbents with the lowest content of the modifier are considered to be more effective for the purification of the plasma from the hydroxylated PhCAs than the sorbent with the highest concentration of the modifier. Simultaneous adsorption of toxic metabolites from the bloodstream and desorption of beneficial ones can be used for a more subtle correction of the patient's condition.

Amine-Grafted Mesoporous Carbons as Benzocaine-Delivery Platforms

Smart porous carriers with defined structure and physicochemical properties are required for releasing the therapeutic drug with precise control of delivery time and location in the body. Due to their non-toxicity, ordered structure, and chemical and thermal stability, mesoporous carbons can be considered modern carriers for active pharmaceutical ingredients whose effectiveness needs frequent dosing algorithms. Here, the novel benzocaine delivery systems based on ordered mesoporous carbons of the cubic structure were obtained with the use of a hard template method and functionalization with amine groups at 40 °C for 8 h. It has been shown that amine grafting strongly modifies the surface chemistry and textural parameters of carbons. All samples indicated good sorption ability towards benzocaine, with evident improvement following the functionalization with the amine groups. The sorption capacity and drug release kinetics were strongly affected by the porosity of carbon carriers and the surface functional groups. The smallest amount of benzocaine (~12%) was released from pristine mesoporous carbon, which could be correlated with strong API–carrier interactions. Faster and more efficient release of the drug was observed in the case of triethylenetetramine modified carbon (~62%). All benzocaine delivery platforms based on amine-grafted mesoporous carbons revealed high permeability through the artificial membrane.

Coconut-shell-derived activated carbon for NIR photo-activated synergistic photothermal-chemodynamic cancer therapy

Exploiting new non-metal-based peroxidase-mimic nanoenzymes for chemodynamic therapy (CDT) in cancer treatment is an active and challenging field. Here, we found that activated carbon nanoparticles (denoted as ANs) fabricated from coconut shell have satisfactory peroxidase-mimic nanoenzyme activity. Based on this positive result, gadodiamide, a clinically used nuclear magnetic imaging contrast agent, was loaded inside the AN pores and encapsulated by polyvinylpyrrolidone (PVP) to obtain Gd@PANs. PANs (ANs modified using PVP) efficiently catalyze the massive decomposition of endogenous hydrogen peroxide (H2O2) inside cancer cells to produce toxic oxidized hydroxyl radicals (˙OH) for the CDT treatment of cancer, but they showed no toxicity toward normal cells. Additionally, under 808 nm laser irradiation, the photothermal conversion efficiency of the PANs reaches 45.20%, ensuring their effective photothermal therapy (PTT) treatment functionality. Simultaneously, during PTT treatment, the heating effect significantly enhances the peroxidase-mimic activity of the PANs to achieve an ideal PTT-CDT synergistic therapeutic outcome. Gd@PANs can also be used for the T1-magnetic resonance imaging (MRI) of tumors to integrate treatment and diagnosis.

Manipulation of the Glass Transition Properties of a High-Solid System Made of Acrylic Acid-N,N'-Methylenebisacrylamide Copolymer Grafted on Hydroxypropyl Methyl Cellulose

Crosslinking of hydroxypropyl methyl cellulose (HPMC) and acrylic acid (AAc) was carried out at various compositions to develop a high-solid matrix with variable glass transition properties. The matrix was synthesized by the copolymerisation of two monomers, AAc and N,N′-methylenebisacrylamide (MBA) and their grafting onto HMPC. Potassium persulfate (K₂S₂O₈) was used to initiate the free radical polymerization reaction and tetramethylethylenediamine (TEMED) to accelerate radical polymerisation. Structural properties of the network were investigated with Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), modulated differential scanning calorimetry (MDSC), small-deformation dynamic oscillation in-shear, thermogravimetric analysis (TGA) and scanning electron microscopy (SEM). The results show the formation of a cohesive macromolecular entity that is highly amorphous. There is a considerable manipulation of the rheological and calorimetric glass transition temperatures as a function of the amount of added acrylic acid, which is followed upon heating by an extensive rubbery plateau. Complementary TGA work demonstrates that the initial composition of all the HPMC-AAc networks is maintained up to 200 °C, an outcome that bodes well for applications of targeted bioactive compound delivery.

Overcoming the paracetamol dose challenge with wrinkled mesoporous carbon spheres

Paracetamol is the most commonly used antipyretic and analgesic drug in the world. The key challenge in paracetamol therapy is associated with the frequency of the dosing. Depending on the gastric filling within 10-20 min paracetamol is released and rapidly absorbed from the gastrointestinal tract. Therefore, it must be taken three or four times a day. To address the dose challenge it is desirable that the paracetamol release profile follows the zero-order kinetic model (constant rate of drug release per unit time). This goal can be achieved by using a suitable porous carrier system. Herein, non-toxic wrinkled mesoporous carbons with unique morphology were synthesized via the hard template method as new carriers for paracetamol. These particles can precisely modulate the release of paracetamol over 24 h in a simulated gastric fluid according to the zero-order kinetic model completely eliminating the initial burst release. Overall, these systems could significantly enhance the bioavailability of paracetamol and prolong its therapeutic effect in numerous diseases such as cold, flu, COVID-19, and severe pain.

Porous Carbon Microparticles as Vehicles for the Intracellular Delivery of Molecules

In this study the application of porous carbon microparticles for the transport of a sparingly soluble material into cells is demonstrated. Carbon offers an intrinsically sustainable platform material that can meet the multiple and complex requirements imposed by applications in biology and medicine. Porous carbon microparticles are attractive as they are easy to handle and manipulate and combine the chemical versatility and biocompatibility of carbon with a high surface area due to their highly porous structure. The uptake of fluorescently labeled microparticles by cancer (HeLa) and normal human embryonic Kidney (HEK 293) cells was monitored by confocal fluorescence microscopy. In this way the influence of particle size, surface functionalization and the presence of transfection agent on cellular uptake were studied. In the presence of transfection agent both large (690 nm) and small microparticles (250 nm) were readily internalized by both cell lines. However, in absence of the transfection agent the uptake was influenced by particle size and surface PEGylation with the smaller nanoparticle size being delivered. The ability of microparticles to deliver a fluorescein dye model cargo was also demonstrated in normal (HEK 293) cell line. Taken together, these results indicate the potential use of these materials as candidates for biological applications.

Design of Paracetamol Delivery Systems Based on Functionalized Ordered Mesoporous Carbons

The oxidized ordered mesoporous carbons of cubic and hexagonal structure obtained by two templating methods (soft and hard) were applied for the first time as delivery systems for paracetamol—the most common antipyretic and analgesic drug in the world. The process of carbon oxidation was performed using an acidic ammonium persulfate solution at 60 °C for 6 h. The functionalization was found to reduce the specific surface area and pore volume of carbon materials, but it also led to an increasing number of acidic oxygen-containing functional groups. The most important element and the novelty of the presented study was the evaluation of adsorption and release ability of carbon carriers towards paracetamol. It was revealed that the sorption capacity and the drug release rate were mainly affected by the materials’ textural parameters and the total amount of surface functional groups, notably different in pristine and oxidized samples. The adsorption of paracetamol on the surface of ordered mesoporous carbons occurred according to different mechanisms: donor–acceptor complexes and hydrogen bond formation. The adsorption kinetics was assessed using pseudo-first- and pseudo-second-order models. The regression results indicated that the adsorption kinetics was more accurately represented by the pseudo-second-order model. Paracetamol was adsorbed onto the carbon materials studied following the Langmuir type isotherm. The presence of oxygen-containing functional groups on the surface of ordered mesoporous carbons enhanced the amount of paracetamol adsorbed and its release rate. The optimal drug loading capacity and expected release pattern exhibited oxidized ordered mesoporous carbon with a hexagonal structure obtained by the hard template method.

Optimizing ibuprofen concentration for rapid pharmacokinetics on biocompatible zinc-based MOF-74 and UTSA-74

Metal-organic frameworks (MOFs) have potential as drug carriers on the basis of their surface areas and pore volumes that allow for high loading and fast release. This study investigated two biocompatible MOFs - Zn MOF-74 and UTSA-74 - for ibuprofen delivery. The effect of drug loading was studied by impregnating the MOFs with 30, 50, and 80 wt% ibuprofen. The samples were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), and N₂ physisorption. From SEM, the MOF structures were maintained at 30 wt% ibuprofen, however, became agglomerated at 50-80 wt% loading, as the drug deposited on the surface and adhered the particles to one another. In the physisorption measurements, the Zn MOF-74 samples decreased in surface area with ibuprofen loading, until they became zero at 80 wt%. In UTSA-74, the drug impregnation was less effective, as 35% of the original surface area was retained in the 80 wt% sample. On the basis of our drug release measurements, 50 wt% ibuprofen loading was found to be optimal on Zn MOF-74, as it gave rise to fast kinetics (k = 0.27 h^-1/2) and high drug concentrations within the first 10 h. In UTSA-74, the fastest release rate was observed at 30 wt% loading (k = 0.22 h^-1/2), as the poor impregnation efficiency blocked diffusion through the MOF pores at higher loading. Color changes of phosphate buffer saline (PBS) solutions at different time intervals also suggested that Zn MOF-74 decomposed during drug release, as it produced yellowing of the PBS solution. On the other hand, UTSA-74 did not discolor the PBS solution, and was concluded to not have dissolved during drug release. From these results, it was concluded that Zn MOF-74 was the superior drug carrier, as it could effectively deliver higher ibuprofen loadings and would dissolve in the process of drug release, thereby reducing its invasiveness in the human body.

Synthesis of a Porous C3N-Derived Framework with High Yield by Gallic Acid Cross-Linking Using Salt Melts

Porous carbon/nitrogen frameworks are an emerging class of noble organic materials with a wide range of potential applications. However, the design and controlled synthesis of those materials are still a challenge. Herein, we present the rational design of such a system with high microporosity, specific surface areas of up to 946 m² g^-1, and excellent condensation yields. The obtained noble frameworks were used for the delivery of larger organic molecules and changed the melting behavior of some daily drug molecules along their highly polarizable surfaces.

The Enhanced and Tunable Sustained Release of Pesticides Using Activated Carbon as a Carrier

The sustained release of pesticides improves drug utilization efficiency and reduces their adverse effects. Activated carbon (AC) is an excellent adsorbent and promising soil conditioner. It has a rich, porous structure and thus can store and gradually release drugs. In this study, three AC materials with surface areas ranging from 800–2000 m²/g were used and two types of modified activated carbons were prepared, and their capacity as drug carriers was evaluated by using 2,4-Dichlorophenoxyacetic acid sodium (2,4-D sodium) as the model pesticide. The preparations were characterized by scanning electron microscopy, nitrogen physical analysis, and zeta potential. The five preparations showed an enhanced and tunable sustained release of drugs. AC1, with the highest specific surface area, possesses the best drug-loading capacity, reaching 679.18 mg/g, but the lowest drug release rate of 32.31% in 96 h. PDA-AC3 has the lowest specific surface area, showing limited drug-loading ability, 82.94 mg/g, but 100% drug release within 72 h. This study suggests that activated carbon has potent applications in agricultural pest control as an inexpensive, effective, controllable, and safe pesticide carrier.

Amorphous Nanosuspensions Aggregated from Paclitaxel⁻Hemoglobulin Complexes with Enhanced Cytotoxicity

Amorphous nanosuspensions (ANSs) enable rapid release and improved delivery of a poorly water-soluble drug; however, their preparation is challenging. Here, using hemoglobin (Hb) as a carrier, ANSs aggregated from paclitaxel (PTX)⁻Hb complexes were prepared to improve delivery of the hydrophobic anti-cancer agent. An affinity study demonstrated strong interaction between Hb and PTX. Importantly, the complexes could aggregate into <300 nm ANSs with high drug loading, which acidic condition facilitated their formation. Furthermore, the ANSs possessed improved cytotoxicity against cancer cells over the crystalline nanosuspensions. Taken together, ANSs aggregated from PTX⁻Hb complexes were developed, which could kill cancer cells with high efficiency.

Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets

The main objective of this study was to develop a pH gradient release pellet with self-emulsifying drug delivery system (SEDDS), which could not only improve the oral bioavailability of Vinpocetine (VIN), a poor soluble drug, but reduce the fluctuation of plasma concentration. First, the liquid VIN SEDDS formulation was prepared. Then the self-emulsifying pH gradient release pellets were prepared by extrusion spheronization technique, and formulation consisted by the liquid SEDDS, absorbent (colloidal silicon dioxide), penetration enhancer (sodium chloride), microcrystalline cellulose, ethyl alcohol, and three coating materials (HPMC, Eudragit L30D55, Eudragit FS30D) were eventually selected. Three kinds of coated pellets were mixed in capsules with the mass ratio of 1:1:1. The release curves of capsules were investigated in vitro under the simulated gastrointestinal conditions. In addition, the oral bioavailability and pharmacokinetics of VIN self-emulsifying pH gradient release pellets, commercial tablets and liquid VIN SEDDS were evaluated in Beagle dogs. The oral bioavailability of self-emulsifying pH gradient release pellets was about 149.8% of commercial VIN tablets, and it was about 86% of liquid VIN SEDDS, but there were no significant difference between liquid SEDDS and self-emulsifying pH gradient release pellets. In conclusion, the self-emulsifying pH gradient release pellets could significantly enhance the absorption of VIN and effectively achieve a pH gradient release. And the self-emulsifying pH gradient release pellet was a promising method to improve bioavailability of insoluble drugs.